Related Experiment Video

Updated: Jun 23, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[Peripartum cardiomyopathy]

Nadia Bouabdallaoui1, Pascal de Groote, Frédéric Mouquet

  • 1Pôle de cardiologie et des maladies vasculaires, CHRU Lille, F-59037 Lille Cedex, France.

Presse Medicale (Paris, France : 1983)
|May 12, 2009
PubMed

Insights

Peripartum cardiomyopathy, a rare heart condition, presents with heart failure during late pregnancy or postpartum. While often reversible, subsequent pregnancies are discouraged if heart function doesn't fully recover.

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine

Context:

  • Peripartum cardiomyopathy (PPCM) is a rare form of dilated cardiomyopathy.
  • Its etiology is multifactorial and not fully understood.
  • Diagnosis relies on clinical heart failure and impaired systolic function.

Purpose:

  • To outline the diagnostic criteria for peripartum cardiomyopathy.
  • To identify key risk factors associated with its development.
  • To describe current management strategies and prognosis.

Summary:

  • PPCM diagnosis involves clinical heart failure and systolic dysfunction, excluding other cardiac conditions like myocardial infarction or myocarditis.
  • Risk factors include advanced maternal age, multiparity, twin pregnancy, African origin, obesity, pre-eclampsia, and prolonged tocolytic therapy.
  • Acute treatment mirrors standard heart failure management; ACE inhibitors and VKAs are contraindicated during pregnancy, with VKA discussed postpartum for low ejection fraction.

Impact:

  • Approximately 50% of patients experience complete recovery of systolic function.
  • The overall mortality risk associated with PPCM is low.
  • Future pregnancies are generally discouraged, particularly if cardiac function remains impaired.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

An Intact Pericardium Ischemic Rodent Model07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...